Retraction notice to "Physicochemical characterization, in vitro and in vivo evaluation of chitosan/carrageenan encumbered with Imatinib mesylate-polysarcosine nanoparticles for sustained drug release and enhanced colorectal cancer targeted therapy" [Int. J. Biol. Macromol. 245 (2023) 125529]
- PMID: 39755066
- DOI: 10.1016/j.ijbiomac.2024.138941
Retraction notice to "Physicochemical characterization, in vitro and in vivo evaluation of chitosan/carrageenan encumbered with Imatinib mesylate-polysarcosine nanoparticles for sustained drug release and enhanced colorectal cancer targeted therapy" [Int. J. Biol. Macromol. 245 (2023) 125529]
Retraction of
-
Physicochemical characterization, in vitro and in vivo evaluation of chitosan/carrageenan encumbered with Imatinib mesylate-polysarcosine nanoparticles for sustained drug release and enhanced colorectal cancer targeted therapy.Int J Biol Macromol. 2023 Aug 1;245:125529. doi: 10.1016/j.ijbiomac.2023.125529. Epub 2023 Jun 26. Int J Biol Macromol. 2023. Retraction in: Int J Biol Macromol. 2025 Mar;293:138941. doi: 10.1016/j.ijbiomac.2024.138941. PMID: 37379942 Retracted.
Similar articles
-
Physicochemical characterization, in vitro and in vivo evaluation of chitosan/carrageenan encumbered with Imatinib mesylate-polysarcosine nanoparticles for sustained drug release and enhanced colorectal cancer targeted therapy.Int J Biol Macromol. 2023 Aug 1;245:125529. doi: 10.1016/j.ijbiomac.2023.125529. Epub 2023 Jun 26. Int J Biol Macromol. 2023. Retraction in: Int J Biol Macromol. 2025 Mar;293:138941. doi: 10.1016/j.ijbiomac.2024.138941. PMID: 37379942 Retracted.
-
Retraction notice to "Chitosan-alginate nanoparticles of cabazitaxel: Design, dual-receptor targeting and efficacy in lung cancer model" [Int. J. Biol. Macromol. 221 (2022) 874-890].Int J Biol Macromol. 2025 Mar;293:138907. doi: 10.1016/j.ijbiomac.2024.138907. Epub 2025 Jan 4. Int J Biol Macromol. 2025. PMID: 39755068 No abstract available.
-
Treatment Access for Gastrointestinal Stromal Tumor in Predominantly Low- and Middle-Income Countries.JAMA Netw Open. 2024 Apr 1;7(4):e244898. doi: 10.1001/jamanetworkopen.2024.4898. JAMA Netw Open. 2024. PMID: 38568688 Free PMC article.
-
From Preformulative Design to In Vivo Tests: A Complex Path of Requisites and Studies for Nanoparticle Ocular Application. Part 1: Design, Characterization, and Preliminary In Vitro Studies.Mol Pharm. 2024 Dec 2;21(12):6034-6061. doi: 10.1021/acs.molpharmaceut.4c00554. Epub 2024 Oct 23. Mol Pharm. 2024. PMID: 39441703 Review.
-
Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer.Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD007814. doi: 10.1002/14651858.CD007814.pub2. Cochrane Database Syst Rev. 2012. PMID: 22895966 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources